StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

AstraZeneca's price to sales ratio was 8.7× on Oct 19, 2026, against 9.5× a year earlier. Over the last 5 years it ranged from 5.4× to 12.1×, with a median of 9.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20268.7×−1.9
2025Dec 31, 202510.6×+1.7
2024Dec 31, 20248.9×−0.5
2023Dec 29, 20239.5×−0.9
2022Dec 30, 202210.3×+4.8
2017Jan 31, 20175.6×−0.0
2016Dec 30, 20165.6×–

More AstraZeneca figures

See a number that looks wrong?